PGRMC1 and PAQR4 are promising molecular targets for a rare subtype of ovarian cancer.
PGRMC1 和 PAQR4 是治疗一种罕见卵巢癌亚型的潜在分子靶点
期刊:Open Life Sciences
影响因子:1.7
doi:10.1515/biol-2022-0982
KozÅowska-Tomczyk Kamila, Borski Norbert, GÅód Paulina, Gogola-Mruk Justyna, Ptak Anna
